Preben Bruun-Nyzell is an executive with more than 20 years of international experience. He is co-founder of 2A Pharma and served as CFO from 2016-2019. He was previously Chief Financial Officer of Qatalum in Qatar, an aluminium producer with annual sales of USD 1.5 billion, and has held senior positions with EMAL in Abu Dhabi, Arqaam Capital in Dubai, Accenture and PwC in London and Hoffmann-La Roche AG in Basel, Switzerland. Preben holds a degree in Business Administration from Lancaster University in the UK and Università Bocconi, Milan, Italy. He is Chairman of the Board of Apoglyx AB and CEO of sister company 2N Pharma ApS.